Onkure Therapeutics (OKUR) traded up 1.35 % during a 24 hours period ending at 06:43 AM Central Europe on Thursday 29th. One Onkure Therapeutics stock can currently be bought for about USD 2.63 on popular exchanges. Current supply of Onkure Therapeutics stocks is 40.4 mn. Onkure Therapeutics has a current market capitalization of USD 99.4 mn and approximately USD 743.2 k worth of Onkure Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Onkure Therapeutics has traded 1.15 % up. Simple moving average of last 200 days is at USD 3.62. The highest price of past 52 weeks was recorded at USD 5.38 on 05/01/2026. 52 weeks low was at USD 2.01 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Anavex Life Sciences (AVXL) traded down -0.76 % and now trades at USD 1.3. Anavex Life Sciences has a market capitalisation of USD 119.1 mn.
Spectra -Reg (SCTQ) traded flat 0 % and now trades at USD 2.41. Spectra -Reg has a market capitalisation of USD 116.7 mn.
Winchester (WSBK) traded down -0.38 % and now trades at USD 13.28. Current market capitalisation for Winchester is USD 119 mn.
Quantumsphere Acquisition (QUMS) traded flat 0 % and now trades at USD 10.4. Quantumsphere Acquisition has a market capitalisation of USD 118.6 mn. Quantumsphere Acquisition has a current price to earnings ratio of 70.05.
Nrx (NRXP) traded flat 0 % and now trades at USD 2.69. Current market capitalisation for Nrx is USD 117.9 mn.
About Onkure Therapeutics
Reneo Pharmaceuticals, Inc. is a pharmaceutical company operating in the health care sector with its base in Irvine, United States. The company specializes in the development of therapies for patients suffering from rare genetic diseases, particularly mitochondrial diseases with significant unmet medical needs. Reneo serves patients in the United States and the United Kingdom and can be accessed online through their webpage at www.reneopharma.com . The company’s stock is traded on the Nasdaq stock exchange.